Premium
Pharmacokinetics, bioavailability, and tissue disposal profiles of Tiamulin fumarate in Nile tilapia ( Oreochromis niloticus ) following oral and intravenous administrations
Author(s) -
Liu Yongtao,
Cao Cuiyu,
Song Yi,
Zhou Shun,
Yang Yibin,
Xu Ning,
Yang Qiuhong,
Dong Jing,
Ai Xiaohui
Publication year - 2021
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1111/jvp.12957
Subject(s) - bioavailability , pharmacokinetics , oreochromis , nile tilapia , volume of distribution , chemistry , tilapia , zoology , pharmacology , withdrawal time , medicine , biology , fish <actinopterygii> , fishery , colorectal cancer , colonoscopy , cancer
Tiamulin fumarate (TIF) is a pleuromutilin antibiotic and has high activity against animal bacterial pathogens including aquatic bacterial pathogens. However, its pharmacokinetic profiles, tissue distribution characteristics and bioavailability in aquatic animals remain unknown. The objective of this study was to investigate the pharmacokinetics and tissue distribution regularities of TIF in tilapia ( Oreochromis niloticus ) following a single oral (PO) dose of 20 mg/kg body weight (bw) and a single intravenous (IV) dose of 5 mg/kg bw at 22 ± 1°C, respectively. TIF concentrations in tilapia plasma and tissues were determined using the isotope dilution HPLC‐HESI‐MS/MS procedure, which was validated according to the guidelines defined by US Food and Drug Administration. TIF was well distributed throughout the body compartments of tilapia judged by the apparent volume of distribution ( V d ) >1 L/kg (6.69 L/kg PO and 1.78 L/kg IV). TIF had a short mean residence time (MRT; 22.82 h PO and 14.61 h IV) and quick total body clearance ( CL b ) (0.62 L kg −1 h −1 PO and 0.60 L kg −1 h −1 IV). The total area under the curve (AUC tot ) of plasma were 32.25 μg h −1 ml −1 (PO) and 8.30 μg h −1 ml (IV), respectively, and the oral absolute bioavailability ( F %) of TIF was calculated to be approximately 97.1%. For tissue distribution, high concentrations of TIF were found in kidney, and the longest MRT was recorded in bile. The withdrawal time (WT) of TIF in muscle, skin, liver, kidney, gill, and bile was 3.75 (4) and 1.79 (2), 1.77 (2) and 2.06 (3), 6.41 (7) and 1.97 (2), 6.95 (7) and 3.98 (4), 4.92 (5) and 2.36 (3), and 7.06 (8) and 6.16 (7) days after PO and IV administration, respectively. The present investigations indicated that TIF was quickly absorbed, well distributed, rapidly eliminated in tilapia, and it could serve as reference data for establishing use regimen and provide useful information for the further development of TIF in aquaculture.